Some groups are willing to resist the confidentiality madness

August 8, 2024 Latest News BioPharma

This is a preview of subscriber content

Subscribe now to continue reading.

Some sectors are actively and publicly resisting the Albanese Government's increasing insistence that consultations on policy matters are contingent on agreement to secrecy. …

Subscribe now to continue reading.

Latest Video

New Stories

Roche announces historic investment to build US manufacturing base
April 23, 2025 - - Latest News
'Reflecting the experience of people living with cancer, Pfizer’s new campaign Part of the Story seeks to reshape the narrative'
April 23, 2025 - - Latest News
US trade agenda looks mostly disinterested in pharmaceuticals
April 23, 2025 - - Latest News
Mesoblast says Ryoncil payer coverage extended to over 100 million Americans
April 22, 2025 - - Australian Biotech
Anatara provides update following completion of analysis of Phase 2 GaRP-IBS clinical trial
April 22, 2025 - - Australian Biotech
Recce Phase 2 trial receives additional approval for treating diabetic patients with topical gel
April 22, 2025 - - Australian Biotech
Race says patient enrolment opened at second site for RC220 solid tumour trial
April 22, 2025 - - Australian Biotech

Some groups are willing to resist the confidentiality madness

This is a preview of subscriber content

Latest Video

Most Read

'Arguing over the proverbial lifejacket whilst patients are in the water drowning. Shame'

Australia increasingly isolated after Europe approves Alzheimer's therapy

Lilly records another win in weight loss in trial of oral GLP-1 agonist

'Reflecting the experience of people living with cancer, Pfizer’s new campaign Part of the Story seeks to reshape the narrative'

Pharmac proposes three-monthly quantities for popular asthma inhalers

New Stories

Roche announces historic investment to build US manufacturing base

'Reflecting the experience of people living with cancer, Pfizer’s new campaign Part of the Story seeks to reshape the narrative'

US trade agenda looks mostly disinterested in pharmaceuticals

Mesoblast says Ryoncil payer coverage extended to over 100 million Americans

Anatara provides update following completion of analysis of Phase 2 GaRP-IBS clinical trial

Recce Phase 2 trial receives additional approval for treating diabetic patients with topical gel

Race says patient enrolment opened at second site for RC220 solid tumour trial

Sign In

Some groups are willing to resist the confidentiality madness

This is a preview of subscriber content

Latest Video

Most Read

'Arguing over the proverbial lifejacket whilst patients are in the water drowning. Shame'

Australia increasingly isolated after Europe approves Alzheimer's therapy

Lilly records another win in weight loss in trial of oral GLP-1 agonist

'Reflecting the experience of people living with cancer, Pfizer’s new campaign Part of the Story seeks to reshape the narrative'

Pharmac proposes three-monthly quantities for popular asthma inhalers

Follow Us

New Stories

Roche announces historic investment to build US manufacturing base

'Reflecting the experience of people living with cancer, Pfizer’s new campaign Part of the Story seeks to reshape the narrative'

US trade agenda looks mostly disinterested in pharmaceuticals

Mesoblast says Ryoncil payer coverage extended to over 100 million Americans

Anatara provides update following completion of analysis of Phase 2 GaRP-IBS clinical trial

Recce Phase 2 trial receives additional approval for treating diabetic patients with topical gel

Race says patient enrolment opened at second site for RC220 solid tumour trial